<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25198" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mitral Regurgitation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Douedi</surname>
            <given-names>Steven</given-names>
          </name>
          <aff>Deborah Heart and Lung Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Douedi</surname>
            <given-names>Hani</given-names>
          </name>
          <aff>Philadelphia College</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Steven Douedi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hani Douedi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25198.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Mitral regurgitation&#x000a0;is a heart condition characterized by the incomplete closure of the mitral valve, leading to the backflow of blood from the left ventricle into the left atrium during systole. This results in a systolic murmur heard at the apex of the heart, often radiating to the left axilla. With a global prevalence of over 2%, mitral regurgitation is a common valvular abnormality with various causes, including congenital conditions, rheumatic fever, and degenerative changes in the valve. This overview aims to cover the essentials of mitral regurgitation, from its pathophysiology and etiology to its evaluation and management, underscoring the importance of early detection and appropriate intervention for optimal patient outcomes.</p>
        <p>By participating in this course, learners comprehensively understand mitral regurgitation, including its clinical features, diagnostic modalities, and therapeutic options. Collaborating with an interprofessional team, including cardiologists, cardiac surgeons, nurses, and imaging specialists, enhances patient outcomes by facilitating a multidisciplinary approach to care. Through shared expertise and coordinated efforts, clinicians can accurately diagnose mitral regurgitation, tailor treatment plans to individual patient needs, and optimize post-intervention care for improved long-term outcomes.&#x000a0;Interdisciplinary collaboration ensures that patients receive holistic care addressing the valvular abnormality, comorbidities, and psychosocial factors, ultimately promoting a better quality of life and overall cardiac health.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between primary and secondary mitral regurgitation etiologies, utilizing diagnostic imaging and echocardiography to distinguish structural abnormalities from functional changes in the mitral valve.</p></list-item><list-item><p>Screen patients with signs of heart failure or valvular heart disease for potential mitral regurgitation, incorporating comprehensive history-taking and physical examination techniques to assess risk factors and identify at-risk populations.</p></list-item><list-item><p>Implement evidence-based treatment protocols for managing mitral regurgitation, including pharmacological interventions, lifestyle modifications, and surgical or transcatheter interventions, to optimize patient outcomes and prevent disease progression.</p></list-item><list-item><p>Collaborate with an interprofessional healthcare team to develop comprehensive care plans tailored to each patient's unique needs, integrating input from specialists and allied health professionals to optimize treatment outcomes and improve patient satisfaction.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25198&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25198">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25198.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mitral regurgitation (MR) is the most common valvular abnormality worldwide, affecting over 2% of the total population, and has a prevalence that&#x000a0;increases with age.<xref ref-type="bibr" rid="article-25198.r1">[1]</xref><xref ref-type="bibr" rid="article-25198.r2">[2]</xref><xref ref-type="bibr" rid="article-25198.r3">[3]</xref>&#x000a0;MR is the retrograde flow of blood from the left ventricle (LV) into the left atrium (LA) through the mitral valve (MV), causing a systolic murmur heard best at the apex of the heart with the sound radiating to the left axilla (see&#x000a0;<bold>Image.</bold>&#x000a0;Mitral Regurgitation During Systole).</p>
        <p>
<bold>Anatomy of Mitral Valve</bold>
</p>
        <p>The mitral valve consists of&#x000a0;2 leaflets (anterior and posterior) sitting within the annulus. The posterior mitral leaflet originates from the LA endocardium. The leaflets&#x000a0;are supported&#x000a0;by a subvalvular apparatus comprising 2 papillary muscles (anterolateral and posteromedial) that arise from the LV myocardium and the chordae tendineae.<xref ref-type="bibr" rid="article-25198.r4">[4]</xref><xref ref-type="bibr" rid="article-25198.r5">[5]</xref>&#x000a0;</p>
        <p><bold>Types of Mitral Regurgitation</bold>&#x000a0;</p>
        <p>Mitral regurgitation&#x000a0;is subdivided&#x000a0;into&#x000a0;<italic toggle="yes">primary</italic>&#x000a0;and&#x000a0;<italic toggle="yes">secondary</italic>.<xref ref-type="bibr" rid="article-25198.r6">[6]</xref>&#x000a0;</p>
        <p>
<bold>Primary mitral regurgitation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Also called degenerative or&#x000a0;organic</p>
          </list-item>
          <list-item>
            <p>Resulting from the structural deformity of or damage to the leaflets, chordae, or&#x000a0;papillary muscles, causing leaflets to close insufficiently during&#x000a0;systole</p>
          </list-item>
          <list-item>
            <p>Common causes: papillary muscle rupture, mitral valve prolapse (MVP), or leaflet perforation&#x000a0;<xref ref-type="bibr" rid="article-25198.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Secondary mitral regurgitation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Also called functional or&#x000a0;ischemic</p>
          </list-item>
          <list-item>
            <p>Due to left ventricular wall motion abnormalities&#x000a0;(ie, ischemic cardiomyopathy) or left ventricular remodeling (ie, dilated cardiomyopathy)<xref ref-type="bibr" rid="article-25198.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>No structural problems with the valve itself&#x000a0;<xref ref-type="bibr" rid="article-25198.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Leads&#x000a0;to mitral annular dilatation or displacement of papillary muscles, causing retrograde flow from improperly closed mitral valve leaflets</p>
          </list-item>
        </list>
        <p>The Carpentier Classification divides mitral regurgitation into&#x000a0;3&#x000a0;types based on the leaflet motion:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type 1:&#x000a0;Normal leaflet motion
<list list-type="bullet"><list-item><p>Caused by annular dilation&#x000a0;or leaflet perforation</p></list-item><list-item><p>Regurgitation jet directed centrally</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Type 2:&#x000a0;Excessive leaflet motion
<list list-type="bullet"><list-item><p>Caused by papillary muscle rupture, chordal rupture, or redundant chordae</p></list-item><list-item><p>Eccentric jet directed away from the involved leaflet</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Type 3:&#x000a0;Restricted leaflet motion
<list list-type="bullet"><list-item><p>IIIa: Leaflet motion restricted in both systole and diastole
<list list-type="bullet"><list-item><p>Caused by&#x000a0;rheumatic heart disease</p></list-item><list-item><p>Normal papillary muscles</p></list-item><list-item><p>Jet may&#x000a0;be centrally or eccentrically directed&#x000a0;</p></list-item></list>
</p></list-item><list-item><p>IIIb: Leaflet motion restricted in&#x000a0;systole&#x000a0;
<list list-type="bullet"><list-item><p>Caused by&#x000a0;papillary muscle dysfunction or left ventricular dilation</p></list-item><list-item><p>Abnormal papillary muscles</p></list-item><list-item><p>Jet may be centrally or eccentrically directed&#x000a0;<xref ref-type="bibr" rid="article-25198.r3">[3]</xref><xref ref-type="bibr" rid="article-25198.r9">[9]</xref><xref ref-type="bibr" rid="article-25198.r10">[10]</xref></p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25198.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Primary Mitral Regurgitation</bold>
</p>
        <p>Degenerative:<bold>&#x000a0;</bold>The underlying pathophysiologic basis for degenerative&#x000a0;mitral regurgitation is most commonly related to myxomatous degeneration of the mitral valve, resulting in mitral valve prolapse (MVP). MVP can occur either as a primary, non-syndromic, or a secondary, syndromic process. In primary MVP, advancing age is the driving factor responsible for disease progression. Connective tissue diseases such as&#x000a0;Marfan syndrome, Ehlers-Danlos syndrome, MASS phenotype, systemic lupus&#x000a0;erythematosus, osteogenesis imperfecta, and pseudoxanthoma elasticum&#x000a0;lead to secondary MVP, causing MR.<xref ref-type="bibr" rid="article-25198.r11">[11]</xref>&#x000a0;</p>
        <p>Congenital: Conditions like isolated&#x000a0;cleft of the mitral valve,<xref ref-type="bibr" rid="article-25198.r12">[12]</xref>&#x000a0;double orifice mitral valve, and parachute mitral valve (PMV), which is a congenital valvular anomaly&#x000a0;where the chordae tendineae are attached to a single papillary muscle, have been linked to causing MR.<xref ref-type="bibr" rid="article-25198.r13">[13]</xref>&#x000a0;While extremely rare, these congenital conditions are well-defined in the literature as causing primary MR.&#x000a0;</p>
        <p>Infectious/rheumatic: With an estimation of over 15 million cases worldwide, rheumatic heart disease is prevalent in developing countries due to a lack of medical resources and vaccinations.<xref ref-type="bibr" rid="article-25198.r14">[14]</xref>&#x000a0;Chronic rheumatic heart disease is associated with pancarditis and has mitral valve involvement, causing regurgitation in almost 100% of cases due to scarring of the valve and valve apparatus.<xref ref-type="bibr" rid="article-25198.r15">[15]</xref><xref ref-type="bibr" rid="article-25198.r16">[16]</xref>&#x000a0;</p>
        <p>
<bold>Secondary Mitral Regurgitation</bold>
</p>
        <p>Left ventricular dilation due to ischemic or nonischemic cardiomyopathy secondarily impairs leaflet coaptation of a structurally normal MV, resulting in secondary MR. Dysfunction and remodeling can lead to apical and lateral papillary muscle displacement, resulting in leaflet tethering, dilation, a flattening of the mitral annulus, and lower valve closing forces.<xref ref-type="bibr" rid="article-25198.r4">[4]</xref>&#x000a0;Reduced closing forces include&#x000a0;LV&#x000a0;contractility,&#x000a0;altered systolic annular contraction, reduced synchronicity between the&#x000a0;2&#x000a0;papillary muscles, and global LV desynchrony, especially in basal segments.</p>
        <p>Papillary muscle rupture: Papillary muscle rupture is&#x000a0;a rare&#x000a0;condition seen in 1% to 2% of patients after myocardial infarction (MI) or infective endocarditis that leads to severe mitral regurgitation due to dysfunction of the papillary muscles.<xref ref-type="bibr" rid="article-25198.r17">[17]</xref><xref ref-type="bibr" rid="article-25198.r18">[18]</xref>&#x000a0;</p>
        <p>Ischemic mitral regurgitation: Ischemic mitral regurgitation<italic toggle="yes">&#x000a0;</italic>results from prior MI associated with&#x000a0;normal&#x000a0;mitral valve leaflets and chordae.&#x000a0;Ischemia of the segments underlying the papillary muscles results in remodeling. This phenomenon causes papillary&#x000a0;muscle displacement, which results in a more apical position of the leaflets, known as a&#x000a0;"seagull sign."<xref ref-type="bibr" rid="article-25198.r19">[19]</xref>&#x000a0;Under Carpentier classification, the&#x000a0;leaflet&#x000a0;dysfunction&#x000a0;resulting&#x000a0;in&#x000a0;the&#x000a0;most common form of ischemic mitral regurgitation is type IIIb due to restricted motions of the leaflet(s) in systole. The degree of exercise-induced increase or decrease in MR relates to changes in LV remodeling, valvular deformation, and LV and papillary muscle synchronicity.</p>
        <p>Congestive heart failure-associated: In a heart failure clinical study of 558 patients with severe congestive heart failure, defined as ejection fraction (EF) less than or equal to 35%,&#x000a0;MR was severe in 4.3% of the patients, moderate to severe in 12.5%, moderate in 21.9%, mild to moderate in 11.8%, mild in 39.1%, and absent or present in 10.4%.<xref ref-type="bibr" rid="article-25198.r20">[20]</xref>&#x000a0;This study identified the correlation between severe congestive heart failure and MR.&#x000a0;</p>
        <p>Atrial fibrillation associated: Results from a retrospective cohort study found atrial fibrillation to cause increased atrial and valve annular size, resulting in functional MR. Of the patients studied, controlling atrial fibrillation and restoring sinus rhythm resulted in an increased reduction of functional MR.<xref ref-type="bibr" rid="article-25198.r21">[21]</xref>&#x000a0;A randomized trial also showed that AF had an association with worsening valvular disease.<xref ref-type="bibr" rid="article-25198.r22">[22]</xref>&#x000a0;</p>
        <p>Hypertrophic cardiomyopathy:&#x000a0;Hypertrophic cardiomyopathy (HCM) can also lead to MR. HCM&#x000a0;is defined&#x000a0;by severe left ventricular hypertrophy, which causes increased papillary muscle mass, bringing them closer together. This phenomenon causes the mitral valve leaflets to become elongated and floppy and pulls the leaflets closer to the left ventricular outflow tract, causing regurgitant&#x000a0;retrograde flow.<xref ref-type="bibr" rid="article-25198.r5">[5]</xref><xref ref-type="bibr" rid="article-25198.r23">[23]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25198.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Mitral regurgitation is a common valvular abnormality occurring in about 10% of the population.<xref ref-type="bibr" rid="article-25198.r1">[1]</xref>&#x000a0;Mitral valve prolapse, which is related to myxomatous degeneration of the mitral valve, is the most common cause of primary mitral regurgitation. Accounting for 2% to 3% of the total population, mitral valve prolapse has been cited as the most common cardiac mitral valvular pathology&#x000a0;worldwide.<xref ref-type="bibr" rid="article-25198.r24">[24]</xref> In developing countries, rheumatic heart disease remains prevalent and is the most common cause of mitral valvular pathology that results in hospital admissions.<xref ref-type="bibr" rid="article-25198.r25">[25]</xref><xref ref-type="bibr" rid="article-25198.r26">[26]</xref></p>
      </sec>
      <sec id="article-25198.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The definition of MR is a retrograde flow of blood from the LV into the left atrium LA through the MV, causing a systolic murmur heard best at the apex of the heart, with the sound radiating to the left axilla.&#x000a0;Mitral regurgitation leads to left ventricular volume overload due to increased stroke volume, caused by&#x000a0;increased&#x000a0;blood volume within the left atrium and an increased preload delivered to the left ventricle during diastole.</p>
        <p>In&#x000a0;chronic progressive MR, ventricular remodeling occurs, allowing maintenance of cardiac output, and an initial increase in EF is usually observed. However, the&#x000a0;effective&#x000a0;EF can be considerably lower depending on the regurgitant fraction. Over time, there is a positive feedback loop by which volume overload from MR causes dilation of the ventricle, widening of the mitral annulus, and diminishing coaptation of leaflets, leading to progressive worsening of the MR.</p>
        <p>Eventually, volume overload becomes so severe that excitation-contraction coupling of the muscle membrane becomes impaired, and wall stress-related afterload on the left ventricle leads to dilation with decreased contractility, resulting in a reduction of EF. In addition, the regurgitant blood from the left ventricle during systole can eventually cause left atrial enlargement, impairment of left atrial contraction, and subsequent atrial fibrillation, leading to&#x000a0;a thrombus in the left atrial appendage.<xref ref-type="bibr" rid="article-25198.r3">[3]</xref><xref ref-type="bibr" rid="article-25198.r27">[27]</xref><xref ref-type="bibr" rid="article-25198.r28">[28]</xref></p>
      </sec>
      <sec id="article-25198.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Mitral valve regurgitation causes a holosystolic murmur that is heard best at the apex of the heart, with the sound radiating to the left axilla (see&#x000a0;<bold>Video.</bold>&#x000a0;Murmur of Mitral Regurgitation). Differentiating the murmur of mitral regurgitation from other systolic murmurs is essential.<xref ref-type="bibr" rid="article-25198.r29">[29]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Mitral valve prolapse: a late systolic murmur heard best at the cardiac apex but with&#x000a0;a mid-systolic click</p>
          </list-item>
          <list-item>
            <p>Tricuspid regurgitation: a high-pitched, blowing, holosystolic murmur heard best at the lower left sternal border, with radiation&#x000a0;to the right lower sternal border; increases with inspiration</p>
          </list-item>
          <list-item>
            <p>Ventral septal defect: a holosystolic murmur (The more significant the ventral septal defect, the quieter the murmur.)</p>
          </list-item>
          <list-item>
            <p>Aortic stenosis: a mid-systolic,&#x000a0;crescendo-decrescendo murmur with radiation toward the neck; gets quieter with Valsalva maneuver or&#x000a0;standing</p>
          </list-item>
          <list-item>
            <p>Pulmonic stenosis: mid-systolic,&#x000a0;crescendo-decrescendo murmur, increases in intensity during inspiration (In severe pulmonic stenosis, the S2 heart sound is widely split.)</p>
          </list-item>
          <list-item>
            <p>Atrial septal defect: mid-systolic murmur with a fixed split S2 heart sound; does not change with&#x000a0;inspiration</p>
          </list-item>
          <list-item>
            <p>Hypertrophic&#x000a0;cardiomyopathy: mid-systolic murmur, heard best medial to the cardiac apex; radiates&#x000a0;to&#x000a0;the left sternal border; murmur is louder with Valsalva and standing</p>
          </list-item>
        </list>
        <p>Clinical findings related to MR&#x000a0;are divided&#x000a0;into&#x000a0;2&#x000a0;categories: those related to the MR itself and those associated with the underlying cause. Maintaining a broad differential diagnosis is&#x000a0;important; with an initially focused history and physical examination, one can establish whether the MR is acute or chronic and thus significantly narrow the possible etiologies.</p>
        <p>
<bold>Acute Mitral Regurgitation</bold>
</p>
        <p>The clinical assessment of the acute onset of mitral regurgitation will elicit findings associated with a precipitous decline in cardiac output and possibly cardiogenic shock. The patient will usually complain of significant dyspnea at rest, exacerbated in the supine position, as well as cough with clear or pink, frothy sputum. They may also endorse symptoms associated with myocardial ischemia, such as chest pain radiating to the neck, jaw, shoulders, or upper extremities accompanied by nausea and diaphoresis. Physical examination may reveal altered mental status, tachycardia (or bradycardia if there is ischemic involvement of the conduction system), hypotension, tachypnea, hypoxemia, and cyanosis.&#x000a0;Additionally, jugular venous distension, diffuse crackles on lung auscultation, and an apical holosystolic murmur with radiation to the axilla on a precordial exam may be present.</p>
        <p>Acute MR is typically related to either papillary muscle rupture from acute coronary syndrome or fulminant destruction of the valvular apparatus secondary to acute bacterial endocarditis. Thus, further clinical assessment should focus on confirming these potentially devastating conditions.</p>
        <p>In the case of acute bacterial endocarditis, there will be signs and symptoms of sepsis, such as fevers and chills. A history of intravenous drug abuse is highly prevalent, and patients may also have comorbid conditions that predispose them to immunocompromise, such as diabetes mellitus and alcohol use disorder. Due to the embolization of vegetative material, there may be a variety of additional clinical findings depending on the ultimate fate of the emboli. Brain involvement of the emboli will produce focal neurologic deficits; renal involvement will result in hematuria or oliguria; and cutaneous involvement will result in Janeway lesions or widespread petechiae.&#x000a0;In contrast to subacute bacterial endocarditis, acute infections typically occur in patients with structurally&#x000a0;normal&#x000a0;heart valves, and, as such, rheumatic heart disease and prosthetic valves are less common in this population. Furthermore, because the route of bacterial delivery to the mitral valve passes through the right side of the heart, concomitant lesions of the tricuspid and pulmonic valves are not uncommon, and these can often&#x000a0;be appreciated&#x000a0;by auscultation of murmurs on physical examination.<xref ref-type="bibr" rid="article-25198.r27">[27]</xref><xref ref-type="bibr" rid="article-25198.r30">[30]</xref></p>
        <p>
<bold>Chronic Mitral Regurgitation</bold>
</p>
        <p>Patients with chronic&#x000a0;mitral regurgitation&#x000a0;often remain asymptomatic until late in the course of the disease.&#x000a0;Clinical findings common to all etiologies include fatigue, dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, dependent edema, weight gain, jugular venous distension, widening of pulse pressure, displaced apical impulse and apical holosystolic murmur with radiation to the axilla. In more advanced cases, there may also be syncope or near syncope, cyanosis, clubbing of digits, hepatomegaly, evidence of ascites with a fluid wave or shifting dullness, gross anasarca, and evidence of pleural or pericardial effusions. These latter findings are reflective of the development of pulmonary hypertension and resultant right ventricular systolic dysfunction from chronic pressure overload. The differential diagnosis is also considerably broader, with specific clinical findings dependent on the etiology.<xref ref-type="bibr" rid="article-25198.r27">[27]</xref></p>
      </sec>
      <sec id="article-25198.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Several tools&#x000a0;are used&#x000a0;to evaluate mitral regurgitation; the patient&#x02019;s history and physical examination should guide the ordering of diagnostic tests.</p>
        <p>
<bold>Echocardiogram</bold>
</p>
        <p>Echocardiography is the primary and essential diagnostic test for diagnosing and assessing&#x000a0;mitral regurgitation.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref>&#x000a0;Transthoracic echocardiography and transesophageal echocardiography provide qualitative and quantitative analysis.&#x000a0;</p>
        <p>Various methods are available to quantify MR.&#x000a0;One such method involves measuring the vena contracta, which represents the width of the regurgitant jet as it exits the regurgitant orifice. This provides insight into the regurgitant orifice area (eg,&#x000a0;vena contracta greater than 7 mm is consistent with severe MR).</p>
        <p>The Doppler volumetric method is also an option for quantifying MR. This method measures the regurgitant volume&#x000a0;as the difference between the mitral and aortic stroke volumes.&#x000a0;Regurgitant volume can&#x000a0;be calculated&#x000a0;as the product of effective regurgitant orifice area (EROA) and MR velocity time integral. Severe MR is quantified as:</p>
        <list list-type="bullet">
          <list-item>
            <p>EROA greater than or equal to 0.2 cm<sup>2</sup></p>
          </list-item>
          <list-item>
            <p>Regurgitant volume greater than or equal to 30 mL</p>
          </list-item>
          <list-item>
            <p>Regurgitant fraction of 50%&#x000a0;or higher&#x000a0;<xref ref-type="bibr" rid="article-25198.r32">[32]</xref><xref ref-type="bibr" rid="article-25198.r33">[33]</xref></p>
          </list-item>
        </list>
        <p>After the initial echocardiographic evaluation, repeat echocardiography&#x000a0;is indicated&#x000a0;for patients with moderate or&#x000a0;greater&#x000a0;MR with or without symptoms every:</p>
        <list list-type="bullet">
          <list-item>
            <p>Severe: 6&#x000a0;to 12 months&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Moderate: 1&#x000a0;to 2 years&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Mild: 3&#x000a0;to 5 years&#x000a0;</p>
          </list-item>
        </list>
        <p>Repeat echocardiography is also a recommendation for patients with any degree of MR and a change in clinical status or physical examination findings.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref><xref ref-type="bibr" rid="article-25198.r34">[34]</xref></p>
        <p>Following MV repair, successful mitigation of MR can&#x000a0;be quantified&#x000a0;via several tools.&#x000a0;One method is measuring&#x000a0;<italic toggle="yes">tenting height,</italic>&#x000a0;which is the&#x000a0;greatest&#x000a0;mid-systolic distance&#x000a0;from leaflet&#x000a0;tips&#x000a0;to&#x000a0;the annular&#x000a0;plane of the mitral valve. The&#x000a0;<italic toggle="yes">tenting area</italic>&#x000a0;is defined&#x000a0;as the area bounded by the mitral annular plane and the anterior and posterior leaflets at mid-systole. In the healthy heart,&#x000a0;normal&#x000a0;values are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tenting height of less than 0.5 cm</p>
          </list-item>
          <list-item>
            <p>Tenting&#x000a0;area of 0 cm<sup>2</sup></p>
          </list-item>
          <list-item>
            <p>Angles of the anterior and posterior mitral leaflet are less than 3 degrees&#x000a0;</p>
          </list-item>
        </list>
        <p>Poor outcomes after&#x000a0;MV repair&#x000a0;are defined&#x000a0;as:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Tenting height of greater than or equal to 1 cm</p>
          </list-item>
          <list-item>
            <p>Tenting area of greater than 2.5&#x000a0;to 3 cm<sup>2&#x000a0;</sup></p>
          </list-item>
          <list-item>
            <p>Complex jets</p>
          </list-item>
          <list-item>
            <p>Posterolateral angle of over 45 degrees&#x000a0;<xref ref-type="bibr" rid="article-25198.r19">[19]</xref><xref ref-type="bibr" rid="article-25198.r35">[35]</xref></p>
          </list-item>
        </list>
        <p>The sphericity index can also quantify the successful mitigation of MR following MV repair. The sphericity index is the ratio between the LV end-diastolic volume and the volume of an imaginary&#x000a0;sphere, with its diameter extending from the midpoint of the annular&#x000a0;plane&#x000a0;to&#x000a0;the&#x000a0;apex.&#x000a0;End-diastolic&#x000a0;diameter exceeding 65 mm,&#x000a0;end-systolic diameter over 51 mm, and systolic sphericity index greater than 0.7&#x000a0;predict&#x000a0;unfavorable outcomes of MV repair.<xref ref-type="bibr" rid="article-25198.r35">[35]</xref></p>
        <p>Successful MV repair can also&#x000a0;be quantified&#x000a0;by assessing distance and wall motion. An interpapillary distance&#x000a0;of over 20 mm, posterior papillary fibrosis distance of more than 40 mm, and lateral wall motion abnormality are associated with poor outcomes after MV repair surgery.</p>
        <p>
<bold>Electrocardiogram&#x000a0;</bold>
</p>
        <p>Atrial fibrillation is the most common electrocardiogram finding in patients with MR.<xref ref-type="bibr" rid="article-25198.r27">[27]</xref>&#x000a0;Patients with atrial fibrillation can also present with more severe MR than patients without arrhythmia.<xref ref-type="bibr" rid="article-25198.r22">[22]</xref>&#x000a0;</p>
        <p>
<bold>Chest Radiography</bold>
</p>
        <p>In patients with chronic MR, cardiomegaly due to left-atrial or right-sided heart enlargement is visible on anterior-posterior x-ray views.<xref ref-type="bibr" rid="article-25198.r27">[27]</xref>&#x000a0;</p>
        <p>
<bold>Exercise Stress Testing</bold>
</p>
        <p>In patients with severe, asymptomatic, primary MR, exercise treadmill testing may provide information regarding the patient&#x02019;s symptom status and exercise tolerance. Exercise echocardiography is&#x000a0;useful&#x000a0;to assess changes in MR severity and pulmonary artery pressure in those symptomatic with non-severe MR at rest.<xref ref-type="bibr" rid="article-25198.r27">[27]</xref>&#x000a0;</p>
        <p>
<bold>Cardiac Catheterization</bold>
</p>
        <p>Cardiac catheterization can&#x000a0;quantify MR volume with high accuracy when clinical findings are&#x000a0;inconsistent&#x000a0;with noninvasive test results.</p>
        <p>
<bold>Cardiac Magnetic Resonance Imaging</bold>
</p>
        <p>Cardiac magnetic resonance imaging (MRI) is an&#x000a0;important&#x000a0;and complementary tool to other modalities for assessing the severity of MR. Cardiac MRI accurately assesses quantitative measurements, including regurgitant volume and regurgitant fraction. Cardiac MRI determination of severe MR demonstrates a stronger correlation with left ventricular remodeling (specifically, smaller left ventricular end-diastolic volume following the elimination of MR) than echocardiography. Clinically, cardiac MRI should help differentiate severe from non-severe MR in patients whose echocardiographic evaluation is inconclusive, particularly if contemplating surgery.<xref ref-type="bibr" rid="article-25198.r36">[36]</xref><xref ref-type="bibr" rid="article-25198.r37">[37]</xref></p>
        <p>
<bold>Biomarkers</bold>
</p>
        <p>In response to heightened wall stress, ventricular myocytes release the biomarker B-type natriuretic peptide (BNP), which correlates with symptom severity and offers prognostic insights for individuals with MR. A BNP level may be&#x000a0;normal&#x000a0;in severe, compensated MR without symptoms or adverse hemodynamic effects. An elevated BNP level is associated with the composite endpoint of the New York Heart Association (NYHA) class III or IV heart failure symptoms, LV dysfunction (ejection fraction less than 60%), or death during follow-up of patients with asymptomatic, severe MR.<xref ref-type="bibr" rid="article-25198.r38">[38]</xref></p>
      </sec>
      <sec id="article-25198.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The choice of medical versus surgical management of&#x000a0;mitral regurgitation depends on the condition&#x02019;s severity, chronicity, comorbidities, and etiology. While some pharmacologic agents can&#x000a0;be used&#x000a0;in MR, the evidence for their use is not strong, and they do not have a recommendation from the American College of Cardiology (ACC) or the American Heart Association (AHA).<xref ref-type="bibr" rid="article-25198.r31">[31]</xref>&#x000a0;Primary severe MR and ischemic severe MR usually receive treatment with valve surgery.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref><xref ref-type="bibr" rid="article-25198.r39">[39]</xref>&#x000a0;</p>
        <p>
<bold>Medical Management of Mitral Regurgitation</bold>
</p>
        <p>Angiotensin-converting enzyme inhibitors (ACE) and angiotensin II receptor blockers (ARBs) have been used in those who are asymptomatic to delay the progression of MR.<xref ref-type="bibr" rid="article-25198.r40">[40]</xref>&#x000a0;The belief is that ACE inhibitors and ARBs can decrease regurgitant volume and LV size in patients with chronic primary MR.<xref ref-type="bibr" rid="article-25198.r41">[41]</xref><xref ref-type="bibr" rid="article-25198.r42">[42]</xref>&#x000a0;However, there are limited supporting results from studies, and their overall role in treating MR is discouraged.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref><xref ref-type="bibr" rid="article-25198.r39">[39]</xref><xref ref-type="bibr" rid="article-25198.r43">[43]</xref>&#x000a0;Some study results have concluded no improvement or survival benefit in patients with MR using ACE inhibitors or ARBs and have even shown worsening outcomes for some.<xref ref-type="bibr" rid="article-25198.r44">[44]</xref><xref ref-type="bibr" rid="article-25198.r45">[45]</xref>&#x000a0;In the setting of hypertrophic cardiomyopathy or mitral valve prolapse, vasodilators have demonstrated an increase in the severity of MR.<xref ref-type="bibr" rid="article-25198.r46">[46]</xref></p>
        <p>Beta-blockers for&#x000a0;the treatment of MR have also been studied, with results revealing little to no benefit with beta-blocking agents in primary MR; some results have shown increased survival benefit with these agents in secondary MR.<xref ref-type="bibr" rid="article-25198.r47">[47]</xref>&#x000a0;One study evaluating the beta blocker&#x000a0;carvedilol supported&#x000a0;its use after demonstrating the preservation of LV function, remodeling, and decreased regurgitant volume.<xref ref-type="bibr" rid="article-25198.r48">[48]</xref>&#x000a0;The ACC/AHA does not have specific recommendations regarding using beta-blockers in patients with MR.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref>&#x000a0;</p>
        <p>Loop diuretics&#x000a0;are believed&#x000a0;to be helpful in conjunction with other pharmacologic agents to further decrease afterload and regurgitant volume, but further studies are necessary to support this association properly.<xref ref-type="bibr" rid="article-25198.r41">[41]</xref>&#x000a0;</p>
        <p>
<bold>Surgical&#x000a0;Management of Mitral Regurgitation</bold>
</p>
        <p>The decision whether to operate is dependent on the underlying cause of MR. Patients with valvular damage due to chordal or papillary muscle rupture or infective endocarditis require surgery. Patients with functional causes of MR, such as ischemia, generally require coronary artery bypass grafting.<xref ref-type="bibr" rid="article-25198.r2">[2]</xref><xref ref-type="bibr" rid="article-25198.r49">[49]</xref>&#x000a0;Patients with acute, symptomatic MR or an EROA of at least 4 cm<sup>2</sup>&#x000a0;require surgical intervention.<xref ref-type="bibr" rid="article-25198.r28">[28]</xref>&#x000a0;Surgery for MR is indicated in patients with LV function deterioration or an end-systolic diameter of 45 mm.<xref ref-type="bibr" rid="article-25198.r50">[50]</xref>&#x000a0;Patients diagnosed with primary severe MR require surgery when symptomatic with an ejection fraction over 30% or asymptomatic with an EF of 30% to 60%.<xref ref-type="bibr" rid="article-25198.r51">[51]</xref>&#x000a0;</p>
        <p>Mitral valve repair has&#x000a0;2&#x000a0;aims:</p>
        <list list-type="bullet">
          <list-item>
            <p>An acceptable surface area of mitral valve leaflet coaptation</p>
          </list-item>
          <list-item>
            <p>Essential annular dilatation of 5&#x000a0;to 8 mm&#x000a0;<xref ref-type="bibr" rid="article-25198.r50">[50]</xref></p>
          </list-item>
        </list>
        <p>The ACC and AHA generally recommend mitral valve repair over replacement due to decreased recurrence of MR after repair.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref><xref ref-type="bibr" rid="article-25198.r52">[52]</xref>&#x000a0;Available data reveal decreased morbidity and mortality after surgical repair over replacement.<xref ref-type="bibr" rid="article-25198.r53">[53]</xref>&#x000a0;However, mitral valve&#x000a0;replacement is favorable over repair when there is extensive tissue destruction, which can occur in some cases of infective endocarditis.<xref ref-type="bibr" rid="article-25198.r49">[49]</xref>&#x000a0;Nevertheless, the newest AHA guidelines clearly state that &#x0201c;mitral valve replacement is preferable to a poor repair.&#x0201d;</p>
        <p>With respect to&#x000a0;surgical replacement of the mitral valve, mechanical prostheses are usually preferable to bioprosthetics due to increased durability and less complicated insertion. Postoperatively, both types require anticoagulation, with bioprosthetic valve replacement requiring only temporary anticoagulation and lifelong anticoagulation with warfarin for mechanical valves.<xref ref-type="bibr" rid="article-25198.r54">[54]</xref>&#x000a0;</p>
        <p>Mitraclip is another surgical procedure proven to be effective and has low morbidity and mortality in patients considered to be at high risk for repair or replacement.<xref ref-type="bibr" rid="article-25198.r54">[54]</xref>&#x000a0;Mitraclip can decrease the mitral valve area, leading to stenosis, and therefore, an area of under 4 cm<sup>2</sup>&#x000a0;is a contraindication for this procedure.<xref ref-type="bibr" rid="article-25198.r55">[55]</xref></p>
      </sec>
      <sec id="article-25198.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Clinical findings related to MR can be divided into 2 categories: those related to the MR itself and those associated with the underlying cause. Maintaining a broad differential diagnosis is crucial. In general, with an initially focused history and physical examination, one can establish whether the MR is acute or chronic and significantly narrow the possible etiologies that can include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Congestive heart failure exacerbation</p>
          </list-item>
          <list-item>
            <p>Acute coronary syndrome</p>
          </list-item>
          <list-item>
            <p>Hemodynamically unstable dysrhythmia</p>
          </list-item>
          <list-item>
            <p>Cardiac tamponade</p>
          </list-item>
          <list-item>
            <p>Pneumothorax</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
          <list-item>
            <p>Septic shock</p>
          </list-item>
          <list-item>
            <p>Thyrotoxicosis or thyroid storm</p>
          </list-item>
        </list>
        <p>The differential diagnosis of chronic mitral regurgitation is also considerably broader, and specific clinical findings depend&#x000a0;on the etiology.</p>
      </sec>
      <sec id="article-25198.s10" sec-type="Staging">
        <title>Staging</title>
        <p>The following staging data for MR is from the 2020 AHA/ACC updated guidelines for&#x000a0;managing heart valve disease, including mitral regurgitation:</p>
        <p>
<bold>Stage A</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>At&#x000a0;risk&#x000a0;of mitral regurgitation (ie, infective endocarditis, mitral valve prolapse)</p>
          </list-item>
          <list-item>
            <p>Normal&#x000a0;valve leaflets, chords, and annulus in patients with coronary disease or cardiomyopathy</p>
          </list-item>
          <list-item>
            <p>Hemodynamics: no MR jet or a small central jet area less than 20% LA on Doppler; small vena contracta less than 3 mm; MR grade can&#x000a0;be described&#x000a0;as trace or trivial</p>
          </list-item>
          <list-item>
            <p>Cardiac consequences: none or those that are unrelated to the valvular changes</p>
          </list-item>
          <list-item>
            <p>Patients at this stage remain asymptomatic&#x000a0;<xref ref-type="bibr" rid="article-25198.r7">[7]</xref><xref ref-type="bibr" rid="article-25198.r31">[31]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Stage B</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Progressive mitral regurgitation occurs in this stage.</p>
          </list-item>
          <list-item>
            <p>ECG assessment of mitral valve anatomy demonstrates mild tethering of mitral leaflets and annular dilation with a normal to slight loss of central coaptation that may be associated with prior infective endocarditis (IE.)</p>
          </list-item>
          <list-item>
            <p>Hemodynamics: EROA is less than 0.4 cm2, regurgitant volume below 60 mL, and regurgitant fraction below 50%. There might be a central regurgitant jet that is only 20% to 40% in magnitude or a late systolic eccentric jet. The venta contracta should not exceed 7 mm in width in all cases. MR grade is 1+ to 2+.</p>
          </list-item>
          <list-item>
            <p>Cardiac consequences:&#x000a0;Left atrial enlargement begins at this stage. Left ventricular dimensions and pulmonary pressures are usually not affected.</p>
          </list-item>
          <list-item>
            <p>Patients at this stage remain asymptomatic.</p>
          </list-item>
        </list>
        <p>
<bold>Stage C</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Asymptomatic severe mitral regurgitation occurs in this stage.</p>
          </list-item>
          <list-item>
            <p>ECG assessment of mitral valve anatomy shows a flail leaflet or severe mitral valve prolapse (MVP) and loss of central coaptation due to leaflet restriction. Causes can be prior IE or a history of chest irradiation.</p>
          </list-item>
          <list-item>
            <p>Hemodynamics: EROA is greater than or equal to 0.4 cm2, regurgitant volume is greater than or equal to 60 mL, regurgitant fraction is greater than or equal to 50%, central regurgitant jet that is greater than 40%, or there is a pansystolic eccentric jet. MR grade is 2+ to 3+.</p>
          </list-item>
          <list-item>
            <p>Cardiac consequences: patients at this stage&#x000a0;are categorized&#x000a0;as C1 (preserved ejection fraction greater than&#x000a0;60%, LV end-systolic diameter is less than 40 mm, or C2 (reduced ejection fraction&#x000a0;less than or equal to 60% or LV end-systolic diameter is&#x000a0;greater&#x000a0;than 40 mm). Both categories exhibit moderate to severe LA enlargement with some LV distension.</p>
          </list-item>
          <list-item>
            <p>Patients at this stage remain&#x000a0;largely&#x000a0;asymptomatic. Some patients may experience symptoms upon severe physical exertion.</p>
          </list-item>
        </list>
        <p>
<bold>Stage D</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Symptomatic severe mitral regurgitation defines this stage.</p>
          </list-item>
          <list-item>
            <p>ECG assessment of mitral valve anatomy is similar to stage C with increased severity and extent.</p>
          </list-item>
          <list-item>
            <p>Hemodynamics:&#x000a0;EROA is&#x000a0;greater&#x000a0;than 0.4 cm<sup>2</sup>,&#x000a0;regurgitant volume greater than or equal to 60 mL, regurgitant&#x000a0;fraction greater than or equal to 50%, vena contracta&#x000a0;greater than or equal to 7 mm, central regurgitant jet that is greater than 40%, or a pansystolic eccentric jet. MR grade is 3+ to 4+.</p>
          </list-item>
          <list-item>
            <p>Cardiac changes as described in grade C with evidence of pulmonary hypertension</p>
          </list-item>
          <list-item>
            <p>Heart failure symptoms due to mitral regurgitation persist even after revascularization and optimization of medical therapy, decreased exercise tolerance, and exertional dyspnea.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25198.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Mitral regurgitation is a common&#x000a0;yet debilitating condition that leads to increased morbidity and mortality, and research is valuable for finding new techniques for managing this condition.<xref ref-type="bibr" rid="article-25198.r56">[56]</xref>&#x000a0;Mitral valve repair and replacement surgeries have been extensively studied and have shown significant improvement in symptoms and mortality.</p>
        <p>Several pertinent studies follow:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>A study of 144 patients with mitral regurgitation found that the 5-year mortality was a remarkable 30% compared to 13% of the age-matched control group. The study also determined that patients with functional mitral regurgitation had an overall increase in morbidity and mortality than those with structural MR.<xref ref-type="bibr" rid="article-25198.r57">[57]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Another study of patients 50 and older with medical treatment alone for mitral regurgitation calculated a yearly mortality rate for moderate and severe organic mitral regurgitation as 3% and 6%, respectively.<xref ref-type="bibr" rid="article-25198.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>A study of 83 patients (asymptomatic, mean age of 56, and undergoing early mitral valve surgery) found residual mitral regurgitation requiring re-repair in 1%, and 4% required a permanent pacemaker. The 10-year survival rate after surgery was 91.5%.<xref ref-type="bibr" rid="article-25198.r58">[58]</xref></p>
          </list-item>
          <list-item>
            <p>Patients with degenerative or rheumatic heart disease and a mean age of 57 years undergoing mitral valve repair had comparable survival rates with individuals in the general population. A study of 125 mitral valve repairs determined postoperative early mortality in 2.4% of the patients and a 10-year survival rate of 84.3%.<xref ref-type="bibr" rid="article-25198.r59">[59]</xref></p>
          </list-item>
          <list-item>
            <p>&#x000a0;A&#x000a0;systematic review and meta-analysis&#x000a0;of patients with severe MR with a reduced ejection fraction (under 40%) compared mitral valve repair surgery versus mitral valve replacement surgery regarding operative mortality. In one study of patients undergoing mitral valve repair, the operative mortality&#x000a0;was determined&#x000a0;to be 5%. However, the mortality rate following mitral valve replacement was estimated to be 10%.<xref ref-type="bibr" rid="article-25198.r53">[53]</xref></p>
          </list-item>
        </list>
        <p>The&#x000a0;greatest&#x000a0;predictor of survival and improvement of symptoms after&#x000a0;MV surgery was shown to be a pre-operative ejection fraction over 60%.<xref ref-type="bibr" rid="article-25198.r60">[60]</xref>&#x000a0;Mitral valve repair is associated with increased survival and decreased morbidity and mortality compared to mitral valve replacement.<xref ref-type="bibr" rid="article-25198.r54">[54]</xref><xref ref-type="bibr" rid="article-25198.r61">[61]</xref></p>
      </sec>
      <sec id="article-25198.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of mitral regurgitation include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Heart failure and related symptoms (ie, shortness of breath)</p>
          </list-item>
          <list-item>
            <p>Atrial fibrillation</p>
          </list-item>
          <list-item>
            <p>Stroke due to arrhythmias&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pulmonary artery hypertension&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dilation of the heart and cardiomegaly&#x000a0;</p>
          </list-item>
        </list>
        <p>Complications of mitral valve surgery or replacement include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infections (including infective endocarditis)</p>
          </list-item>
          <list-item>
            <p>Bleeding</p>
          </list-item>
          <list-item>
            <p>Clotting and stenosis of new valve</p>
          </list-item>
          <list-item>
            <p>Valve dysfunction</p>
          </list-item>
          <list-item>
            <p>Arrhythmias&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25198.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Most patients can&#x000a0;be discharged&#x000a0;postoperatively if no complications (ie, infection or bleeding) arise during the procedure or hospitalization.</p>
        <p>Postoperative guidelines have undergone study, and the following are the recommendations:</p>
        <list list-type="bullet">
          <list-item>
            <p>A postoperative ECG should be performed soon after the procedure before discharge and is periodically necessary to assess left ventricular function, especially if symptoms arise.</p>
          </list-item>
          <list-item>
            <p>Lifelong anticoagulation, typically with warfarin, is indicated for mechanical or prosthetic valve replacements.</p>
          </list-item>
          <list-item>
            <p>Clinicians should initiate antibiotic prophylaxis for infective endocarditis before dental, oral, or upper respiratory tract procedures in patients with a mechanical or prosthetic valve or a history of endocarditis.<xref ref-type="bibr" rid="article-25198.r27">[27]</xref><xref ref-type="bibr" rid="article-25198.r62">[62]</xref><xref ref-type="bibr" rid="article-25198.r63">[63]</xref></p>
          </list-item>
        </list>
        <p>Exercise therapy and cardiac rehabilitation after heart valve surgery have been extensively studied and&#x000a0;are generally recommended. Some data&#x000a0;supports improved exercise&#x000a0;capacity&#x000a0;and ejection fraction; however, further studies&#x000a0;are needed&#x000a0;to develop a definite&#x000a0;correlation.<xref ref-type="bibr" rid="article-25198.r64">[64]</xref><xref ref-type="bibr" rid="article-25198.r65">[65]</xref><xref ref-type="bibr" rid="article-25198.r66">[66]</xref><xref ref-type="bibr" rid="article-25198.r67">[67]</xref></p>
        <p>In a retrospective study of 105 patients who underwent heart valve surgery, the mean time&#x000a0;for them to return to work was about&#x000a0;5&#x000a0;months.&#x000a0;These patients also showed improved ejection fraction, with 78.4% of patients studied categorized in NYHA stage I or II compared with 38.1% before heart valve&#x000a0;surgery.<xref ref-type="bibr" rid="article-25198.r68">[68]</xref></p>
      </sec>
      <sec id="article-25198.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>A cardiologist is necessary for the diagnosis and medical management of MR, and a cardiothoracic surgeon consult would be necessary if surgery is indicated.</p>
      </sec>
      <sec id="article-25198.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients could benefit from understanding the symptoms indicative of severe MR and recognizing when to seek medical assistance. Additionally, it is valuable for patients with MR to understand the criteria for surgery and available treatment options. While patients diagnosed with moderate or severe secondary mitral regurgitation may benefit from surgery, with an improvement in symptoms and quality of life, there has been no proven survival benefit from surgery. In most cases, it is not indicated or performed.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>In the older adult population (eg, 60+), study results have shown that surgeons opt not to perform this surgery due to&#x000a0;no&#x000a0;survival&#x000a0;benefit.&#x000a0;Several factors affect treatment decisions. In a study of 1741 patients with mitral regurgitation, only 60.31% received surgical treatment. This number decreased to 54.71% in the age group&#x000a0;greater&#x000a0;than 60.<xref ref-type="bibr" rid="article-25198.r69">[69]</xref></p>
          </list-item>
          <list-item>
            <p>In another study of 396 patients diagnosed with severe mitral regurgitation, 49%&#x000a0;were not operated&#x000a0;on due to comorbid conditions.<xref ref-type="bibr" rid="article-25198.r70">[70]</xref></p>
          </list-item>
          <list-item>
            <p>Surgical decision-making should consider impaired left-ventricular ejection fraction, older age, and comorbid conditions.&#x000a0;</p>
          </list-item>
        </list>
        <p>Consult with a cardiologist regarding&#x000a0;the management of&#x000a0;mitral regurgitation, as patient treatment options can vary depending on several factors.</p>
      </sec>
      <sec id="article-25198.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Mitral valve regurgitation&#x000a0;is an increasingly common valvular heart disease associated with a wide range of causes and symptoms. Due to comorbidities, MR has a significant mortality rate, especially in the population older than 60, and the only definitive treatment is surgery.<xref ref-type="bibr" rid="article-25198.r6">[6]</xref>&#x000a0;MR is universally under-diagnosed and under-treated, leading to its increased prevalence.<xref ref-type="bibr" rid="article-25198.r56">[56]</xref>&#x000a0;The ACC and AHA have developed evidence-based guidelines for evaluating, diagnosing, and managing valvular diseases.<xref ref-type="bibr" rid="article-25198.r31">[31]</xref></p>
        <p>Interprofessional healthcare team members should recognize that early diagnosis and management have proven to be lifesaving, and advancements in medicine and valvular studies have contributed to a significant decrease in morbidity and mortality of this disease. Developing a team of specialized healthcare professionals, such as cardiologists and cardiac surgeons, has significantly improved patient&#x000a0;care due to efficiency and efficacy in managing the patient and the decision-making process.<xref ref-type="bibr" rid="article-25198.r71">[71]</xref>&#x000a0;</p>
        <p>Nurses trained in cardiology monitor patients, provide education, and facilitate team communication, reporting all observations to the appropriate clinical staff. Pharmacists review the dosing and potential interactions of medications&#x000a0;and educate patients and the healthcare team. Patient care does not end in the operating room; postoperative care and cardiac rehabilitation require a team of healthcare professionals who are crucial for improved patient outcomes and morale.&#x000a0;</p>
      </sec>
      <sec id="article-25198.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25198&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25198">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/mitral-regurgitation/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25198">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25198/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25198">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25198.s18">
        <fig id="article-25198.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Mitral Regurgitation During Systole. Retrograde flow of blood through the mitral valve from the left ventricle to the left atrium. (1) Mitral valve (2) Left Ventricle (3) Left Atrium (4) Aorta. J Heuser, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/pictures/edit/Public Domain">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Mitral_Regurgitation_scheme1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25198.s19">
        <fig id="article-25198.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Murmur of Mitral Regurgitation.&#x000a0;Murmur of mitral regurgitation as heard on auscultation of the heart. Contributed by K Humphreys</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Mitral_Regurgitation.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25198.s20">
        <title>References</title>
        <ref id="article-25198.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arimie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mehra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clavijo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Matthews</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Shavelle</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Incidence and treatment of severe primary mitral regurgitation in contemporary clinical practice.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>960</fpage>
            <page-range>960-963</page-range>
            <pub-id pub-id-type="pmid">30060923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Weidman-Evans</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Clawson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing and managing mitral regurgitation.</article-title>
            <source>JAAPA</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>11</fpage>
            <page-range>11-14</page-range>
            <pub-id pub-id-type="pmid">28452853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apostolidou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Maslow</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Poppas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Primary mitral valve regurgitation: Update and review.</article-title>
            <source>Glob Cardiol Sci Pract</source>
            <year>2017</year>
            <month>Mar</month>
            <day>31</day>
            <volume>2017</volume>
            <issue>1</issue>
            <fpage>e201703</fpage>
            <pub-id pub-id-type="pmid">31139637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asgar</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Mar</month>
            <day>31</day>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>1231</fpage>
            <page-range>1231-1248</page-range>
            <pub-id pub-id-type="pmid">25814231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dal-Bianco</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Beaudoin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Handschumacher</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Basic mechanisms of mitral regurgitation.</article-title>
            <source>Can J Cardiol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>971</fpage>
            <page-range>971-81</page-range>
            <pub-id pub-id-type="pmid">25151282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enriquez-Sarano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akins</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mitral regurgitation.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>Apr</month>
            <day>18</day>
            <volume>373</volume>
            <issue>9672</issue>
            <fpage>1382</fpage>
            <page-range>1382-94</page-range>
            <pub-id pub-id-type="pmid">19356795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Skubas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JD</given-names>
              </name>
              <collab>American College of Cardiology/American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Jun</month>
            <day>10</day>
            <volume>63</volume>
            <issue>22</issue>
            <fpage>2438</fpage>
            <page-range>2438-88</page-range>
            <pub-id pub-id-type="pmid">24603192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmitto</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Mokashi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Bolman</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>FY</given-names>
              </name>
            </person-group>
            <article-title>Functional mitral regurgitation.</article-title>
            <source>Cardiol Rev</source>
            <year>2010</year>
            <season>Nov-Dec</season>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>285</fpage>
            <page-range>285-91</page-range>
            <pub-id pub-id-type="pmid">20926937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moura</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pierard</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Agricola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Tribouilloy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hagendorff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monin</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Badano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>European Association of Echocardiography</collab>
            </person-group>
            <article-title>European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease).</article-title>
            <source>Eur J Echocardiogr</source>
            <year>2010</year>
            <month>May</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>307</fpage>
            <page-range>307-32</page-range>
            <pub-id pub-id-type="pmid">20435783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginghin&#x00103;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vl&#x00103;daia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghiorghiu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Serban</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Jurcu&#x00163;</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Echocardiography in congenital mitral valve regurgitation--the liaison between cardiologist and surgeon.</article-title>
            <source>J Med Life</source>
            <year>2009</year>
            <season>Oct-Dec</season>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>407</fpage>
            <page-range>407-13</page-range>
            <pub-id pub-id-type="pmid">20108755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spartalis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tzatzaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Spartalis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Athanasiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Damaskos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garmpis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Voudris</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Mitral valve prolapse: an underestimated cause of sudden cardiac death-a current review of the literature.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>5390</fpage>
            <page-range>5390-5398</page-range>
            <pub-id pub-id-type="pmid">29312750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heinle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nihill</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Isolated cleft of the mitral valve: clinical spectrum and course.</article-title>
            <source>Tex Heart Inst J</source>
            <year>2009</year>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>553</fpage>
            <page-range>553-6</page-range>
            <pub-id pub-id-type="pmid">20069080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouskas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Giannakoulas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kallifatidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karvounis</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Parachute-like mitral valve as a cause of mitral regurgitation.</article-title>
            <source>Hippokratia</source>
            <year>2016</year>
            <season>Jul-Sep</season>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>238</fpage>
            <page-range>238-240</page-range>
            <pub-id pub-id-type="pmid">29097893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seckeler</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Hoke</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.</article-title>
            <source>Clin Epidemiol</source>
            <year>2011</year>
            <month>Feb</month>
            <day>22</day>
            <volume>3</volume>
            <fpage>67</fpage>
            <page-range>67-84</page-range>
            <pub-id pub-id-type="pmid">21386976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chockalingam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gnanavelu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Elangovan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chockalingam</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Clinical spectrum of chronic rheumatic heart disease in India.</article-title>
            <source>J Heart Valve Dis</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>577</fpage>
            <page-range>577-81</page-range>
            <pub-id pub-id-type="pmid">14565709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r16">
          <label>16</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Sika-Paotonu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beaton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raghu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Steer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carapetis</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Acute Rheumatic Fever and Rheumatic Heart Disease</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Ferretti</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Fischetti</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <source><italic>Streptococcus pyogenes</italic>: Basic Biology to Clinical Manifestations [Internet]</source>
            <publisher-name>University of Oklahoma Health Sciences Center</publisher-name>
            <publisher-loc>Oklahoma City (OK)</publisher-loc>
            <year>2017</year>
            <month>3</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">28379675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yatskar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rubinstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Silbiger</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Papillary muscle rupture following acute myocardial infarction: Anatomic, echocardiographic, and surgical insights.</article-title>
            <source>Echocardiography</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>1702</fpage>
            <page-range>1702-1707</page-range>
            <pub-id pub-id-type="pmid">29082549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Burton</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Beier</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Papillary Muscle Rupture</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">29763151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varma</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Krishna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jose</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Madkaiker</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Ischemic mitral regurgitation.</article-title>
            <source>Ann Card Anaesth</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>432</fpage>
            <page-range>432-439</page-range>
            <pub-id pub-id-type="pmid">28994679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Borgeson</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Mitral regurgitation in patients with advanced systolic heart failure.</article-title>
            <source>J Card Fail</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>285</fpage>
            <page-range>285-91</page-range>
            <pub-id pub-id-type="pmid">15309693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gertz</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Raina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saghy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zado</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Callans</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Marchlinski</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Silvestry</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2011</year>
            <month>Sep</month>
            <day>27</day>
            <volume>58</volume>
            <issue>14</issue>
            <fpage>1474</fpage>
            <page-range>1474-81</page-range>
            <pub-id pub-id-type="pmid">21939832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Gertz</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Silvestry</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Wiegers</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Hermiller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Segar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Heimansohn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Homma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Argenziano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jollis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lampert</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glower</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Apr</month>
            <day>03</day>
            <volume>59</volume>
            <issue>14</issue>
            <fpage>1312</fpage>
            <page-range>1312-9</page-range>
            <pub-id pub-id-type="pmid">22464260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hwang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Rim</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Dynamic change of mitral apparatus as potential cause of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.</article-title>
            <source>Eur J Echocardiogr</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-25</page-range>
            <pub-id pub-id-type="pmid">20693545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Freed</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and clinical outcome of mitral-valve prolapse.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Jul</month>
            <day>01</day>
            <volume>341</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">10387935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moraes</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tarasoutchi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Clinical and epidemiological profile of patients with valvular heart disease admitted to the emergency department.</article-title>
            <source>Einstein (Sao Paulo)</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-8</page-range>
            <pub-id pub-id-type="pmid">25003918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nkomo</surname>
                <given-names>VT</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa.</article-title>
            <source>Heart</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>93</volume>
            <issue>12</issue>
            <fpage>1510</fpage>
            <page-range>1510-9</page-range>
            <pub-id pub-id-type="pmid">18003682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maganti</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Sarano</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
            </person-group>
            <article-title>Valvular heart disease: diagnosis and management.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2010</year>
            <month>May</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>483</fpage>
            <page-range>483-500</page-range>
            <pub-id pub-id-type="pmid">20435842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enriquez-Sarano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Avierinos</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Messika-Zeitoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Detaint</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Capps</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nkomo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schaff</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Tajik</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Quantitative determinants of the outcome of asymptomatic mitral regurgitation.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Mar</month>
            <day>03</day>
            <volume>352</volume>
            <issue>9</issue>
            <fpage>875</fpage>
            <page-range>875-83</page-range>
            <pub-id pub-id-type="pmid">15745978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r29">
          <label>29</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Thomas</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Heaton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Makaryus</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <chapter-title>Physiology, Cardiovascular Murmurs</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30247833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DePace</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Nestico</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Morganroth</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute severe mitral regurgitation. Pathophysiology, clinical recognition, and management.</article-title>
            <source>Am J Med</source>
            <year>1985</year>
            <month>Feb</month>
            <volume>78</volume>
            <issue>2</issue>
            <fpage>293</fpage>
            <page-range>293-306</page-range>
            <pub-id pub-id-type="pmid">3881945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Jneid</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Jun</month>
            <day>20</day>
            <volume>135</volume>
            <issue>25</issue>
            <fpage>e1159</fpage>
            <page-range>e1159-e1195</page-range>
            <pub-id pub-id-type="pmid">28298458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gillam</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Trento</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Defining "severe" secondary mitral&#x000a0;regurgitation: emphasizing an integrated approach.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Dec</month>
            <day>30</day>
            <volume>64</volume>
            <issue>25</issue>
            <fpage>2792</fpage>
            <page-range>2792-801</page-range>
            <pub-id pub-id-type="pmid">25541133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hua</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Flaherty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>506</fpage>
            <page-range>506-13</page-range>
            <pub-id pub-id-type="pmid">21730026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Skubas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JD</given-names>
              </name>
              <collab>ACC/AHA Task Force Members</collab>
            </person-group>
            <article-title>2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2014</year>
            <month>Jun</month>
            <day>10</day>
            <volume>129</volume>
            <issue>23</issue>
            <fpage>2440</fpage>
            <page-range>2440-92</page-range>
            <pub-id pub-id-type="pmid">24589852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dudzinski</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic assessment of ischemic mitral regurgitation.</article-title>
            <source>Cardiovasc Ultrasound</source>
            <year>2014</year>
            <month>Nov</month>
            <day>21</day>
            <volume>12</volume>
            <fpage>46</fpage>
            <pub-id pub-id-type="pmid">25416497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uretsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Argulian</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Use of Cardiac Magnetic Resonance Imaging in Assessing Mitral Regurgitation: Current&#x000a0;Evidence.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2018</year>
            <month>Feb</month>
            <day>06</day>
            <volume>71</volume>
            <issue>5</issue>
            <fpage>547</fpage>
            <page-range>547-563</page-range>
            <pub-id pub-id-type="pmid">29406861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Siden</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Rodriguez-Diego</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alakbarli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Di Franco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weinsaft</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Utility of cardiac magnetic resonance for evaluation of mitral regurgitation prior to mitral valve surgery.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>Suppl 4</issue>
            <fpage>S246</fpage>
            <page-range>S246-S256</page-range>
            <pub-id pub-id-type="pmid">28540067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdel Fattah</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Girgis</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>El Khashab</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ashour</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Ezzat</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>B-type Natriuretic Peptide as an Index of Symptoms and Severity of Chronic Rheumatic Mitral Regurgitation.</article-title>
            <source>Heart Views</source>
            <year>2016</year>
            <season>Jan-Mar</season>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-12</page-range>
            <pub-id pub-id-type="pmid">27293523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borer</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Drug Therapy for Heart Valve Diseases.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Sep</month>
            <day>15</day>
            <volume>132</volume>
            <issue>11</issue>
            <fpage>1038</fpage>
            <page-range>1038-45</page-range>
            <pub-id pub-id-type="pmid">26371236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Pastorius</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harwood</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Practice variation among cardiovascular physicians in management of patients with mitral regurgitation.</article-title>
            <source>Am J Cardiol</source>
            <year>2009</year>
            <month>Jan</month>
            <day>15</day>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>255</fpage>
            <page-range>255-61</page-range>
            <pub-id pub-id-type="pmid">19121447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>WRITING COMMITTEE MEMBERS</collab>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Geraci</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Horwich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wilkoff</surname>
                <given-names>BL</given-names>
              </name>
              <collab>American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Oct</month>
            <day>15</day>
            <volume>128</volume>
            <issue>16</issue>
            <fpage>e240</fpage>
            <page-range>e240-327</page-range>
            <pub-id pub-id-type="pmid">23741058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pastorius</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Pharmacotherapy in the treatment of mitral regurgitation: a systematic review.</article-title>
            <source>J Heart Valve Dis</source>
            <year>2012</year>
            <month>May</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-85</page-range>
            <pub-id pub-id-type="pmid">22808826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>de Leon</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Faxon</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Freed</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Gaasch</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Lytle</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>O'Rourke</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Shanewise</surname>
                <given-names>JS</given-names>
              </name>
              <collab>2006 Writing Committee Members</collab>
              <collab>American College of Cardiology/American Heart Association Task Force</collab>
            </person-group>
            <article-title>2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.</article-title>
            <source>Circulation</source>
            <year>2008</year>
            <month>Oct</month>
            <day>07</day>
            <volume>118</volume>
            <issue>15</issue>
            <fpage>e523</fpage>
            <page-range>e523-661</page-range>
            <pub-id pub-id-type="pmid">18820172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sampaio</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Grinberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leite</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Tarasoutchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chalela</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Izaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Mady</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease.</article-title>
            <source>Am J Cardiol</source>
            <year>2005</year>
            <month>Jul</month>
            <day>01</day>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>117</fpage>
            <page-range>117-21</page-range>
            <pub-id pub-id-type="pmid">15979448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Supino</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hai</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Herrold</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Hochreiter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borer</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Relation of indirect vasodilator use to prognosis in patients with chronic severe mitral regurgitation.</article-title>
            <source>Cardiology</source>
            <year>2014</year>
            <volume>129</volume>
            <issue>4</issue>
            <fpage>262</fpage>
            <page-range>262-6</page-range>
            <pub-id pub-id-type="pmid">25402846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slipczuk</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rafique</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Davila</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Beigel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pressman</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The Role of Medical Therapy in Moderate to Severe Degenerative Mitral Regurgitation.</article-title>
            <source>Rev Cardiovasc Med</source>
            <year>2016</year>
            <volume>17</volume>
            <issue>1-2</issue>
            <fpage>28</fpage>
            <page-range>28-39</page-range>
            <pub-id pub-id-type="pmid">27667378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varadarajan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Appel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Duvvuri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction.</article-title>
            <source>Am J Cardiol</source>
            <year>2008</year>
            <month>Sep</month>
            <day>01</day>
            <volume>102</volume>
            <issue>5</issue>
            <fpage>611</fpage>
            <page-range>611-5</page-range>
            <pub-id pub-id-type="pmid">18721522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comin-Colet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Corral</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Manito</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Hospital</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Roca</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Nofrerias</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Valdovinos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Esplugas</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.</article-title>
            <source>Transplant Proc</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>177</fpage>
            <page-range>177-8</page-range>
            <pub-id pub-id-type="pmid">11959238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stout</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Verrier</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Acute valvular regurgitation.</article-title>
            <source>Circulation</source>
            <year>2009</year>
            <month>Jun</month>
            <day>30</day>
            <volume>119</volume>
            <issue>25</issue>
            <fpage>3232</fpage>
            <page-range>3232-41</page-range>
            <pub-id pub-id-type="pmid">19564568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madesis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsakiridis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Katsikogiannis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Machairiotis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kougioumtzi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kesisis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tsiouda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Beleveslis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koletas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zarogoulidis</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Review of mitral valve insufficiency: repair or replacement.</article-title>
            <source>J Thorac Dis</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>6 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S39</fpage>
            <page-range>S39-51</page-range>
            <pub-id pub-id-type="pmid">24672698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Badhwar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Afonso</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Elmariah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kithcart</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>2017 ACC Expert Consensus Decision&#x000a0;Pathway on the Management&#x000a0;of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2017</year>
            <month>Nov</month>
            <day>07</day>
            <volume>70</volume>
            <issue>19</issue>
            <fpage>2421</fpage>
            <page-range>2421-2449</page-range>
            <pub-id pub-id-type="pmid">29055505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Borer</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Surgical Treatment of Ischemic Mitral Regurgitation: Valve Repair Versus Replacement.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">28101839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andalib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chetrit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Filion</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Th&#x000e9;riault-Lauzier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Buithieu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martucci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bolling</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Piazza</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Review and Meta-Analysis of Outcomes Following Mitral Valve Surgery in Patients with Significant Functional Mitral Regurgitation and Left Ventricular Dysfunction.</article-title>
            <source>J Heart Valve Dis</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>696</fpage>
            <page-range>696-707</page-range>
            <pub-id pub-id-type="pmid">28290169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alegria-Barrero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Franzen</surname>
                <given-names>OW</given-names>
              </name>
            </person-group>
            <article-title>Mitral Regurgitation - A Multidisciplinary Challenge.</article-title>
            <source>Eur Cardiol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-53</page-range>
            <pub-id pub-id-type="pmid">30310485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Conrad Smith</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Crock</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Cavalcante</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic evaluation and guidance for MitraClip procedure.</article-title>
            <source>Cardiovasc Diagn Ther</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>616</fpage>
            <page-range>616-632</page-range>
            <pub-id pub-id-type="pmid">29302467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dziadzko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Clavel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dziadzko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Medina-Inojosa</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Michelena</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maalouf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nkomo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thapa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Enriquez-Sarano</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Outcome and undertreatment of mitral regurgitation: a community cohort study.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Mar</month>
            <day>10</day>
            <volume>391</volume>
            <issue>10124</issue>
            <fpage>960</fpage>
            <page-range>960-969</page-range>
            <pub-id pub-id-type="pmid">29536860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindmark</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>S&#x000f6;derberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teien</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>N&#x000e4;slund</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up of mitral valve regurgitation--importance of mitral valve pathology and left ventricular function on survival.</article-title>
            <source>Int J Cardiol</source>
            <year>2009</year>
            <month>Oct</month>
            <day>02</day>
            <volume>137</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-50</page-range>
            <pub-id pub-id-type="pmid">18707770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tom&#x00161;i&#x0010d;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hiemstra</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>van Hout</surname>
                <given-names>FMA</given-names>
              </name>
              <name>
                <surname>van Brakel</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Versteegh</surname>
                <given-names>MIM</given-names>
              </name>
              <name>
                <surname>Marsan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Klautz</surname>
                <given-names>RJM</given-names>
              </name>
              <name>
                <surname>Palmen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Long-term results of mitral valve repair for severe mitral regurgitation in asymptomatic patients.</article-title>
            <source>J Cardiol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>72</volume>
            <issue>6</issue>
            <fpage>473</fpage>
            <page-range>473-479</page-range>
            <pub-id pub-id-type="pmid">29861131</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Costa</surname>
                <given-names>FDAD</given-names>
              </name>
              <name>
                <surname>Colatusso</surname>
                <given-names>DFF</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>GLDS</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>KCS</given-names>
              </name>
              <name>
                <surname>Botta</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Balbi Filho</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Veloso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>ADA</given-names>
              </name>
              <name>
                <surname>Colatusso</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Results of Mitral Valve Repair.</article-title>
            <source>Braz J Cardiovasc Surg</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-31</page-range>
            <pub-id pub-id-type="pmid">29617498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toledano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rudski</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Huynh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>B&#x000e9;&#x000ef;que</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sampalis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morin</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists.</article-title>
            <source>Can J Cardiol</source>
            <year>2007</year>
            <month>Mar</month>
            <day>01</day>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <page-range>209-14</page-range>
            <pub-id pub-id-type="pmid">17347692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC)</collab>
              <collab>European Association for Cardio-Thoracic Surgery (EACTS)</collab>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alfieri</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Andreotti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Antunes</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bar&#x000f3;n-Esquivias</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Carrel</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Evangelista</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pierard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sch&#x000e4;fers</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Schuler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stepinska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Swedberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takkenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Von Oppell</surname>
                <given-names>UO</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Zembala</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Guidelines on the management of valvular heart disease (version 2012).</article-title>
            <source>Eur Heart J</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>33</volume>
            <issue>19</issue>
            <fpage>2451</fpage>
            <page-range>2451-96</page-range>
            <pub-id pub-id-type="pmid">22922415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butchart</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Gohlke-B&#x000e4;rwolf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Antunes</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Caterina</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cormier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bjornstad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Leport</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
              <collab>Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology</collab>
            </person-group>
            <article-title>Recommendations for the management of patients after heart valve surgery.</article-title>
            <source>Eur Heart J</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>26</volume>
            <issue>22</issue>
            <fpage>2463</fpage>
            <page-range>2463-71</page-range>
            <pub-id pub-id-type="pmid">16103039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seiler</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Management and follow up of prosthetic heart valves.</article-title>
            <source>Heart</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>90</volume>
            <issue>7</issue>
            <fpage>818</fpage>
            <page-range>818-24</page-range>
            <pub-id pub-id-type="pmid">15201262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sibilitz</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Risom</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Thygesen</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Johansen</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Gluud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lindschou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hassager</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>K&#x000f8;ber</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Zwisler</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Cardiac rehabilitation increases physical capacity but not mental health after heart valve surgery: a randomised clinical trial.</article-title>
            <source>Heart</source>
            <year>2016</year>
            <month>Dec</month>
            <day>15</day>
            <volume>102</volume>
            <issue>24</issue>
            <fpage>1995</fpage>
            <page-range>1995-2003</page-range>
            <pub-id pub-id-type="pmid">27492941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meurin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Iliou</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ben Driss</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pierre</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Corone</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cristofini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tabet</surname>
                <given-names>JY</given-names>
              </name>
              <collab>Working Group of Cardiac Rehabilitation of the French Society of Cardiology</collab>
            </person-group>
            <article-title>Early exercise training after mitral valve repair: a multicentric prospective French study.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>1638</fpage>
            <page-range>1638-44</page-range>
            <pub-id pub-id-type="pmid">16162769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pollmann</surname>
                <given-names>AGE</given-names>
              </name>
              <name>
                <surname>Frederiksen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prescott</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Rehabilitation After Heart Valve Surgery: IMPROVEMENT IN EXERCISE CAPACITY AND MORBIDITY.</article-title>
            <source>J Cardiopulm Rehabil Prev</source>
            <year>2017</year>
            <month>May</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>191</fpage>
            <page-range>191-198</page-range>
            <pub-id pub-id-type="pmid">27755256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sibilitz</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Risom</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Gluud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lindschou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kober</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hassager</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Zwisler</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Exercise-based cardiac rehabilitation for adults after heart valve surgery.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Mar</month>
            <day>21</day>
            <volume>3</volume>
            <fpage>CD010876</fpage>
            <pub-id pub-id-type="pmid">26998683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lunel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Corbineau</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boulmier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chaperon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guillo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dewitte</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Leguerrier</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Return to work after cardiac valvular surgery. Retrospective study of a series of 105 patients].</article-title>
            <source>Arch Mal Coeur Vaiss</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-22</page-range>
            <pub-id pub-id-type="pmid">12613145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhuge</surname>
                <given-names>RQ</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>XP</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>XL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>MZ</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and treatment options for mitral regurgitation in elderly inpatients.</article-title>
            <source>J Geriatr Cardiol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>428</fpage>
            <page-range>428-433</page-range>
            <pub-id pub-id-type="pmid">30108615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirabel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Messika-Zeitoun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>D&#x000e9;taint</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vanoverschelde</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Butchart</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Ravaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?</article-title>
            <source>Eur Heart J</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>1358</fpage>
            <page-range>1358-65</page-range>
            <pub-id pub-id-type="pmid">17350971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25198.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heuts</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Olsthoorn</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hermans</surname>
                <given-names>SMM</given-names>
              </name>
              <name>
                <surname>Streukens</surname>
                <given-names>SAF</given-names>
              </name>
              <name>
                <surname>Vainer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cheriex</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Segers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maessen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Sardari Nia</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary decision-making in mitral valve disease: the mitral valve heart team.</article-title>
            <source>Neth Heart J</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>176</fpage>
            <page-range>176-184</page-range>
            <pub-id pub-id-type="pmid">30742250</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
